HUP0105439A2 - Process for the synthesis of hiv protease inhibitors - Google Patents
Process for the synthesis of hiv protease inhibitorsInfo
- Publication number
- HUP0105439A2 HUP0105439A2 HU0105439A HUP0105439A HUP0105439A2 HU P0105439 A2 HUP0105439 A2 HU P0105439A2 HU 0105439 A HU0105439 A HU 0105439A HU P0105439 A HUP0105439 A HU P0105439A HU P0105439 A2 HUP0105439 A2 HU P0105439A2
- Authority
- HU
- Hungary
- Prior art keywords
- synthesis
- protease inhibitors
- hiv protease
- hiv
- inhibitors
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000004030 hiv protease inhibitor Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9805898.5A GB9805898D0 (en) | 1998-03-20 | 1998-03-20 | Process for the sythesis of hiv protease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0105439A2 true HUP0105439A2 (en) | 2002-06-29 |
| HUP0105439A3 HUP0105439A3 (en) | 2002-08-28 |
Family
ID=10828884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0105439A HUP0105439A3 (en) | 1998-03-20 | 1999-03-18 | Process for the synthesis of hiv protease inhibitors |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6281367B1 (hu) |
| EP (1) | EP1066276B1 (hu) |
| JP (1) | JP3363439B2 (hu) |
| KR (1) | KR100555278B1 (hu) |
| CN (1) | CN1308319C (hu) |
| AP (1) | AP1226A (hu) |
| AT (1) | ATE242772T1 (hu) |
| AU (1) | AU751534B2 (hu) |
| BR (1) | BR9908970A (hu) |
| CA (1) | CA2324217C (hu) |
| CZ (1) | CZ299193B6 (hu) |
| DE (1) | DE69908761T2 (hu) |
| DK (1) | DK1066276T3 (hu) |
| EA (1) | EA003022B1 (hu) |
| EE (1) | EE04750B1 (hu) |
| ES (1) | ES2203090T3 (hu) |
| GB (1) | GB9805898D0 (hu) |
| HK (1) | HK1032047A1 (hu) |
| HR (1) | HRP20000609B1 (hu) |
| HU (1) | HUP0105439A3 (hu) |
| ID (1) | ID26587A (hu) |
| IL (1) | IL138127A (hu) |
| IS (1) | IS2273B (hu) |
| NO (1) | NO317648B1 (hu) |
| NZ (1) | NZ506563A (hu) |
| PL (1) | PL201810B1 (hu) |
| PT (1) | PT1066276E (hu) |
| RS (1) | RS49954B (hu) |
| SK (1) | SK283939B6 (hu) |
| TR (1) | TR200002698T2 (hu) |
| WO (1) | WO1999048885A1 (hu) |
| ZA (1) | ZA200004482B (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE218541T1 (de) | 1992-08-25 | 2002-06-15 | Searle & Co | Hydroxyethylaminosulfonamide verwendbar als inhibitoren retroviraler proteasen |
| US6548706B2 (en) * | 1999-12-23 | 2003-04-15 | Aerojet Fine Chemicals Llc | Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl) -p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines |
| ATE401298T1 (de) * | 1999-12-23 | 2008-08-15 | Ampac Fine Chemicals Llc | Verbessertes verfahren zur herstellung von 2s,3s- n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)- - nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin |
| US7700645B2 (en) * | 2002-05-16 | 2010-04-20 | Tibotec Pharmaceuticals Ltd. | Pseudopolymorphic forms of a HIV protease inhibitor |
| US7772411B2 (en) | 2003-12-23 | 2010-08-10 | Tibotec Pharmaceuticals Ltd. | Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate |
| TWI482775B (zh) | 2008-09-01 | 2015-05-01 | Tibotec Pharm Ltd | 用於製備（３ｒ，３ａｓ，６ａｒ）－六氫呋喃并〔２，３－ｂ〕呋喃－３－基（１ｓ，２ｒ）－３－〔〔（４－胺基苯基）磺醯基〕（異丁基）胺基〕－１－苯甲基－２－羥基丙基胺基甲酸酯之方法 |
| TR201807704T4 (tr) | 2010-01-27 | 2018-06-21 | Viiv Healthcare Co | Anti-viral tedavi. |
| EP2614055A2 (en) | 2010-09-10 | 2013-07-17 | Lupin Limited | Process for preparation of substantially pure fosamprenavir calcium and its intermediates |
| CN111233794A (zh) * | 2020-03-27 | 2020-06-05 | 江巨东 | 一种安普那韦的精制方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1071930A (zh) * | 1991-07-10 | 1993-05-12 | 伊莱利利公司 | 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂 |
| ATE218541T1 (de) * | 1992-08-25 | 2002-06-15 | Searle & Co | Hydroxyethylaminosulfonamide verwendbar als inhibitoren retroviraler proteasen |
| IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
| US5723490A (en) * | 1992-09-08 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | THF-containing sulfonamide inhibitors of aspartyl protease |
-
1998
- 1998-03-20 GB GBGB9805898.5A patent/GB9805898D0/en not_active Ceased
-
1999
- 1999-03-18 PL PL342602A patent/PL201810B1/pl not_active IP Right Cessation
- 1999-03-18 CZ CZ20003457A patent/CZ299193B6/cs not_active IP Right Cessation
- 1999-03-18 HU HU0105439A patent/HUP0105439A3/hu unknown
- 1999-03-18 EE EEP200000568A patent/EE04750B1/xx not_active IP Right Cessation
- 1999-03-18 AU AU29475/99A patent/AU751534B2/en not_active Ceased
- 1999-03-18 US US09/646,277 patent/US6281367B1/en not_active Expired - Lifetime
- 1999-03-18 ES ES99910543T patent/ES2203090T3/es not_active Expired - Lifetime
- 1999-03-18 WO PCT/GB1999/000852 patent/WO1999048885A1/en active IP Right Grant
- 1999-03-18 PT PT99910543T patent/PT1066276E/pt unknown
- 1999-03-18 ID IDW20001857A patent/ID26587A/id unknown
- 1999-03-18 NZ NZ506563A patent/NZ506563A/en unknown
- 1999-03-18 RS YUP-559/00A patent/RS49954B/sr unknown
- 1999-03-18 EP EP99910543A patent/EP1066276B1/en not_active Expired - Lifetime
- 1999-03-18 CA CA002324217A patent/CA2324217C/en not_active Expired - Fee Related
- 1999-03-18 BR BR9908970-0A patent/BR9908970A/pt not_active Application Discontinuation
- 1999-03-18 DE DE69908761T patent/DE69908761T2/de not_active Expired - Lifetime
- 1999-03-18 JP JP2000537868A patent/JP3363439B2/ja not_active Expired - Lifetime
- 1999-03-18 SK SK1373-2000A patent/SK283939B6/sk not_active IP Right Cessation
- 1999-03-18 DK DK99910543T patent/DK1066276T3/da active
- 1999-03-18 IL IL13812799A patent/IL138127A/xx not_active IP Right Cessation
- 1999-03-18 EA EA200000859A patent/EA003022B1/ru unknown
- 1999-03-18 TR TR2000/02698T patent/TR200002698T2/xx unknown
- 1999-03-18 AP APAP/P/2000/001911A patent/AP1226A/en active
- 1999-03-18 CN CNB998042242A patent/CN1308319C/zh not_active Expired - Fee Related
- 1999-03-18 AT AT99910543T patent/ATE242772T1/de not_active IP Right Cessation
- 1999-03-18 KR KR1020007010359A patent/KR100555278B1/ko not_active IP Right Cessation
-
2000
- 2000-08-29 ZA ZA200004482A patent/ZA200004482B/en unknown
- 2000-08-29 IS IS5605A patent/IS2273B/is unknown
- 2000-09-15 HR HR20000609A patent/HRP20000609B1/xx not_active IP Right Cessation
- 2000-09-19 NO NO20004664A patent/NO317648B1/no not_active IP Right Cessation
-
2001
- 2001-03-30 HK HK01102333A patent/HK1032047A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3662799A (en) | Processes for the synthesis of oligomeric compounds | |
| PL342113A1 (en) | Sulphonamidic derivatives useful as precursors of aspartil protease inhibitors | |
| AU1601100A (en) | Improved processes for the synthesis of oligomeric compounds | |
| EG22541A (en) | Process for the production of olefins | |
| HUP0103946A2 (hu) | Eljárás olefinek előállítására | |
| IL133363A (en) | Process for the production of herapin | |
| IL138127A (en) | Process for the synthesis of hiv protease inhibitors | |
| GB9515802D0 (en) | Hiv protease inhibitors useful for the treatment of aids | |
| ZA98898B (en) | Process for the production of halogeno-o-hydroxydiphenyl compounds | |
| EP0785786A4 (en) | MICROBIAL SYNTHESIS OF HIV PROTEASE INHIBITORS | |
| HK1052350A1 (zh) | 一種合成嗎啉基苯類化合物的新方法 | |
| PL343629A1 (en) | Improved process for the manufacture of n-(1-cyanoalkyl)-2-phenoxypropionamide derivatives | |
| SI1066276T1 (en) | Process for the synthesis of hiv protease inhibitors | |
| IL124178A (en) | Process for the production of distryryl-biphenyl compounds | |
| EP0912170A4 (en) | HIV PROTEASE INHIBITORS USEFUL IN AIDS TREATMENT | |
| EP0785989A4 (en) | MICROBIAL SYNTHESIS OF INHIBITORS OF THE HIV PROTEASE | |
| HUP0203214A3 (en) | Process for preparing intermediates applicable for synthesis of hiv protease inhibitor | |
| EP0914125A4 (en) | HIV protease inhibitors, useful in AIDS treatment. | |
| HUP0103105A3 (en) | Process for the synthesis of exochelins | |
| GC0000365A (en) | Process for the production of olefins | |
| HUP0302387A3 (en) | Process for the preparation of protected 1-(1-aminoalkyl)-oxiranes | |
| AU3515700A (en) | Process for the synthesis of dihydropyridones | |
| HUP0004950A3 (en) | Process for the production of formylimidazoles | |
| GB9613487D0 (en) | HIV protease inhibitors useful for the treatment of aids | |
| GB9609663D0 (en) | HIV Protease inhibitors useful for the treatment of aids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |